FIGO Stage III Ovarian Cancer
|
disease |
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Carcinoma of anal canal
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
4
|
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2000 |
Biotinidase Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
6
|
4
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
lung sarcoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Squamous Cell Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8
|
|
0.010 |
None |
< 0.001 |
1 |
|
1993 |
1993 |
Benign bone neoplasm
|
group |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
In situ cancer
|
phenotype |
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Localized Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
8
|
1
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Ovarian cancer stage III
|
disease |
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Digestive System Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
10
|
2
|
0.020 |
None |
1.000 |
1 |
|
2008 |
2016 |
Secondary malignant neoplasm of axilla
|
disease |
|
Neoplastic Process
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Hypertyrosinemia
|
disease |
|
Disease or Syndrome
|
12
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Bladder Squamous Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Mucopolysaccharidosis I
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
14
|
7
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Secondary malignant neoplasm of female breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
14
|
1
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Metaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Thyroid cancer metastatic
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
15
|
|
0.010 |
None |
< 0.001 |
1 |
|
1994 |
1994 |
Invasive pituitary adenoma
|
disease |
Neoplasms; Nervous System Diseases; Endocrine System Diseases
|
Neoplastic Process
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Tyrosinemias
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
16
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Nicolaides Baraitser syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Disease or Syndrome
|
16
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Eye Neoplasms
|
group |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
17
|
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Pfaundler-Hurler Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
17
|
11
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
stage, colon cancer
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
18
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Endometriosis of pelvis
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
20
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Deficiency of butyryl-CoA dehydrogenase
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
21
|
6
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |